Pyxis Oncology Stock (NASDAQ:PYXS), Quotes and News Summary

Q: What sector and industry does Pyxis Oncology (PYXS) operate in?

Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.

Open	$3.480
Close	$3.800
Volume / Avg.	924.383K / 565.230K
Day Range	3.480 - 3.880
52 Wk Range	1.350 - 6.850
Market Cap	$223.776M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	4.19%
Days to Cover	4.4

Recent News

Pyxis Oncology, Inc. Reports Q1 Loss, Tops Revenue Estimates

Pyxis Oncology, Inc. (NASDAQ: PYXS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.

Avi Kapoor

Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pyxis Oncology (PYXS) stock?

You can purchase shares of Pyxis Oncology (NASDAQ: PYXS) through any online brokerage.

View our list of the best stock brokerages.

Who are Pyxis Oncology's (PYXS) competitors?

Other companies in Pyxis Oncology’s space includes: Renovaro (NASDAQ:RENB), Innate Pharma (NASDAQ:IPHA), Opthea (NASDAQ:OPT), INmune Bio (NASDAQ:INMB) and Lineage Cell Therapeutics (AMEX:LCTX).

What is the target price for Pyxis Oncology (PYXS) stock?

The latest price target for Pyxis Oncology (NASDAQ: PYXS) was reported by HC Wainwright & Co. on Thursday, May 16, 2024. The analyst firm set a price target for 7.00 expecting PYXS to rise to within 12 months (a possible 84.21% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Pyxis Oncology (PYXS)?

The stock price for Pyxis Oncology (NASDAQ: PYXS) is $3.8 last updated June 7, 2024 at 4:00 PM EDT.

Does Pyxis Oncology (PYXS) pay a dividend?

There are no upcoming dividends for Pyxis Oncology.

When is Pyxis Oncology (NASDAQ:PYXS) reporting earnings?

Pyxis Oncology’s Q2 earnings are confirmed for Friday, August 9, 2024.

Is Pyxis Oncology (PYXS) going to split?

There is no upcoming split for Pyxis Oncology.

What sector and industry does Pyxis Oncology (PYXS) operate in?

Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-